Table 1. The correlation of NAP1L1 or HDGF protein expression with clinicopathological parameters in gliomas.
Characteristics | N | NAP1L1 | P value | HDGF | P value | ||
Low | High | Low | High | ||||
Age (years) | |||||||
<55 | 86 | 29 | 57 | 0.866 | 36 | 50 | 0.936 |
≥55 | 22 | 7 | 15 | 9 | 13 | ||
Gender | |||||||
Male | 59 | 21 | 38 | 0.585 | 27 | 32 | 0.343 |
Female | 49 | 15 | 34 | 18 | 31 | ||
WHO grade | |||||||
I | 7 | 6 | 1 | 0.013 | 6 | 1 | 0.026 |
II | 43 | 15 | 28 | 21 | 22 | ||
III | 18 | 6 | 12 | 6 | 12 | ||
IV | 40 | 9 | 31 | 12 | 28 | ||
Ki-67 index | |||||||
≥20% | 60 | 12 | 48 | 0.001 | 19 | 41 | 0.018 |
<20% | 48 | 24 | 24 | 26 | 22 | ||
KPS | |||||||
≥80 | 84 | 32 | 52 | 0.050 | 40 | 44 | 0.019 |
<80 | 24 | 4 | 20 | 5 | 19 | ||
Vital status | |||||||
Alive | 45 | 21 | 24 | 0.013 | 26 | 19 | 0.004 |
Dead | 63 | 15 | 48 | 19 | 44 | ||
Recurrence | |||||||
No | 23 | 16 | 7 | <0.001 | 16 | 7 | 0.002 |
Yes | 85 | 20 | 65 | 29 | 56 |